Study Details

Citation

DiClemente, R. J., Wingood, G. M., Sales, J. M., Brown, J. L., Rose, E. S., Davis, T. L., Lang, D. L., Caliendo, A., & Hardin, J. W. (2014). Efficacy of a telephone-delivered sexually transmitted infection/human immunodeficiency virus prevention maintenance intervention for adolescents: A randomized clinical trial. JAMA Pediatrics, 168(10), 938–946.

Steiner, R. J., Swartzendruber, A. L., Rose, E., and DiClemente, R. J. (2014). Monitoring knowledge among family, sexually transmitted infections, and sexual partnership characteristics of African American adolescent females. Sexually Transmitted Diseases, 41(10), 601–604. doi:10.1097/OLQ.0000000000000188

Program or Component Study?
Program component
Program or Component Name

Booster sexual risk reduction counseling implemented as a supplement to HORIZONS

Show Evidence of Effectiveness
Yes
Study Rating and Explanation
High

This study received a high study quality rating because it is a low-attrition randomized controlled trial with no known issues that would suggest the findings cannot be attributed to the program

Program Information

Program Type
Sexual health education
Program Length
10 to 20 sessions

Evaluation Setting

Evaluation Setting
Health clinic or medical facility

Study Sample

Average Age Group
18 or 19
Majority Racial/Ethnic Group
African American or Black
Sex
Young female

Research Design

Assignment Method
Randomized controlled trial
Sample Size

701

Number of Follow-Ups

6

Length of Last Follow-Up

36 months after start of intervention

Year of Last Data Collection
2010

Study Findings

Result Number of Partners
Potentially favorable evidence
Result Contraceptive Use
Favorable evidence
Reviewed Studies
High-Quality Randomized Trial
Protocol Version
Version 7.0
Details

Booster sexual health counseling, implemented as part of the evidence-based teen pregnancy prevention program HORIZONS, was evaluated using a randomized controlled trial design involving 701 Black young women ages 14 to 20 recruited from three health clinics in Atlanta, Georgia. This booster sexual health risk reduction counseling component is designed as a prevention maintenance intervention to support the use of behaviors that prevent sexually transmitted infections (STIs) and HIV and reduce the incidence of STIs. The component included a total of 18 telephone calls by health educators, each about 10 minutes long, every eight weeks during a three-year period after the conclusion of the in-person clinic-based HORIZONS program.

Participants in the evaluation were randomly assigned to either a treatment group that received HORIZONS plus the booster sexual risk reduction counseling component, or a control group that received HORIZONS plus an identical dosage of general health promotion counseling phone calls. Computer-assisted, self-administered interviews and self-collected vaginal swab specimens were collected at baseline and at 6, 12, 18, 24, 30, and 36 months after the primary HORIZONS program ended.

At 36 months after the primary HORIZONS program ended (immediately after the phone calls ended), the study found that adolescents assigned to receive sexual health counseling phone calls reported a significantly higher proportion of their vaginal sex episodes as condom-protected in the past 90 days (effect size = 2.2) and in the past six months (effect size = 2.2) relative to adolescents assigned to receive the general health promotion counseling calls. Adolescents assigned to sexual health counseling also reported having significantly fewer vaginal sex partners in the past six months (effect size = -2.2).

The study also examined the impacts of the booster sexual health risk reduction counseling on measures of prevalence of STIs (chlamydial and gonococcal) using a pooled sample of participants who completed any of the six follow-ups. Findings for these outcomes did not meet the review standards because the pooled sample had high attrition and did not demonstrate baseline equivalence. In addition, the authors did not report impact estimates for each follow-up separately.

Finally, the study examined impacts on measures of sexual activity while high on drugs or alcohol, but findings for those measures fell outside the scope of the review.

Effect Sizes
{"0": {"ProgramName":"Booster sexual risk reduction counseling implemented as a supplement to HORIZONS","StudyID":"PPRER011339","ManuscriptID":"PPRER011339","Rating":"High","OutcomeName":"Proportion of condom use in past 90 days","OutcomeDomain":"Contraceptive Use","OutcomeDichotomous":"No","SampleType":"Full sample","FUTimingMonths":"36","FUReference":"Baseline","MeanTreat":"0.5","MeanComp":"0.41","TpperES":"2.246","StatSigRepEffect":"Yes","RepEffectFavorable":"Yes","RepEffectMeet":"Yes"},"1": {"ProgramName":"Booster sexual risk reduction counseling implemented as a supplement to HORIZONS","StudyID":"PPRER011339","ManuscriptID":"PPRER011339","Rating":"High","OutcomeName":"Proportion of condom use in past 6 months","OutcomeDomain":"Contraceptive Use","OutcomeDichotomous":"No","SampleType":"Full sample","FUTimingMonths":"36","FUReference":"Baseline","MeanTreat":"0.51","MeanComp":"0.42","TpperES":"2.246","StatSigRepEffect":"Yes","RepEffectFavorable":"Yes","RepEffectMeet":"Yes"},"2": {"ProgramName":"Booster sexual risk reduction counseling implemented as a supplement to HORIZONS","StudyID":"PPRER011339","ManuscriptID":"PPRER011339","Rating":"High","OutcomeName":"Number of vaginal sex partners in past 6 months","OutcomeDomain":"Number of Sexual Partners","OutcomeDichotomous":"No","SampleType":"Full sample","FUTimingMonths":"36","FUReference":"Baseline","MeanTreat":"1.42","MeanComp":"1.69","TpperES":"-2.246","StatSigRepEffect":"Yes","RepEffectFavorable":"Yes","RepEffectMeet":"Yes"}}

NA = Not available. This means the authors did not report the information in the manuscripts associated with the studies we reviewed.

a This information was not available whenever authors did not report information for the treatment and comparison groups separately on outcome means, standard deviations, and/or sample sizes.

b Authors reported that the program effect (impact) estimate is statistically significant with a p-value of less than 0.05 based on a two-tailed test.

c For some outcomes, having less of that outcome is favorable. In those cases, an effect with a negative sign is favorable to the treatment group (that is, the treatment group had a more favorable outcome than the comparison group, on average).

d An effect shows credibly estimated, statistically significant evidence whenever it has a p-value of less than 0.05 based on a two-tailed test, includes the appropriate adjustment for clustering (if applicable), and it is not based on an endogenous subgroup.

Language directly from the program model developer or authors.